Glucotrack to Present at LSI USA '26 Medtech Innovation Summit

Core Insights - Glucotrack, Inc. is set to present its continuous blood glucose monitor (CBGM) technology at the LSI USA '26 Summit, highlighting its innovative approach to diabetes management [1][2]. Company Overview - Glucotrack, Inc. focuses on the design, development, and commercialization of novel technologies for diabetes management, specifically a long-term implantable continuous blood glucose monitoring system [4]. - The CBGM system is designed to measure blood glucose levels continuously, featuring a sensor longevity of up to three years, no on-body wearable component, and minimal calibration requirements [5]. Presentation Details - Dr. Paul V. Goode will present on March 17, 2026, at 8:15 a.m. PT, discussing the positive results from the first-in-human study, regulatory strategy, and commercialization plans for a U.S. clinical trial [2][3]. - The presentation aims to address substantial unmet needs in diabetes management and promote a user-friendly experience for patients [3].